Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-057 - Addition of Custirsen, a Clusterin (CLU) Inhibitor, to Docetaxel in Stage IV Non-Small Cell Lung Cancer (NSCLC): Design of the ENSPIRIT Phase 3 Study

      09:30 - 09:30  |  Author(s): J. Von Pawel

      • Abstract

      Loading...

  • +

    O03 - NSCLC - Targeted Therapies I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:J. Ross
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium B, Level 1
    • +

      O03.02 - Randomized Phase-3 trial (INSPIRE) of Necitumumab plus Cisplatin-Pemetrexed versus Cisplatin-Pemetrexed Alone as First-Line Therapy in Stage IV Non-Squamous NSCLC

      10:40 - 10:50  |  Author(s): L. Paz-Ares

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO06 - NSCLC - Chemotherapy I

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:R. Perez-Soler
    • Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Ballroom A, Level 1
    • +

      MO06.07 - Daily administration of oral vinorelbine: data from a phase I trial in patients with advanced Non-Small Cell Lung Cancer (NSCLC)

      16:50 - 16:55  |  Author(s): A. Tufman

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.11 - Poster Session 3 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.11-040 - Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomized, double-blind, placebo-controlled phase 3 study in second-line advanced non-small cell lung cancer (NSCLC) patients

      09:30 - 09:30  |  Author(s): S. Novello

      • Abstract

      Loading...

  • +

    Best of Posters - IASLC Selection - Part 2

    • Type: Exhibit Showcase Session
    • Track:
    • Presentations: 4
    • Coordinates: 10/30/2013, 09:55 - 10:25, Exhibit Hall, Ground Level
    • +

      P2.11-024 - Efficacy Analysis for Molecular Subgroups in MARQUEE: a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial of Tivantinib (ARQ 197) Plus Erlotinib versus Placebo plus Erlotinib in Previously Treated Patients with Locally Advanced or Metastatic, Non-squamous, Non- small Cell Lung Cancer (NSCLC)

      10:00 - 10:05  |  Author(s): S. Novello

      • Abstract

      Loading...